Company intelligence / Profile preview

Cyclotope

Houston, Texas, United Statessofie.com ↗

Ownership: Private
Development stage: Commercial

Overview

Cyclotope Radiopharmacy was a regional provider of radiopharmaceuticals serving over 400,000 patients annually at 700 clinical practices. It supported R&D and contract manufacturing for pharmaceutical partners before being acquired by SOFIE in June 2019. The site now operates as part of SOFIE’s national network focused on molecular imaging and theranostics.

Modalities: RadiopharmaceuticalsDiagnostic agentsTheranostic agents
Industry: Contract Manufacturing Organization

Partnerships

Houston Cyclotron PartnersSOFIE's pharma partnerships network

Beyond the preview

Go deeper on Cyclotope.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cyclotope.

Explore the full profile